PRTN3 and rheumatoid arthritis: RA is diagnosed according to the EULAR/ACR classification criteria revised in 2010, which, beyond clinical disease manifestations, comprise serological biomarkers, such as rheumatoid factors (RF) and anti-citrullinated protein antibodies (ACPA) [1,3,6].